Medtronic

GE HealthCare

IQVIA

Unlocking New Revenue Streams: 3 Medical Device Companies Monetizing Data and Analytics

UBS Group

UBS Downgrades GE HealthCare to Sell, Raises PT to $77 from $73

GE HealthCare's 15min chart shows MACD, KDJ Death Crosses.

GE Healthcare's 15-minute chart sees MACD Death Cross, KDJ Death Cross.

GE Healthcare's 15min chart shows MACD Death Cross, Bollinger Bands Narrowing.

Catalyst<ul> <li>Most analysts rate GEHC Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state, and the direction is not clear enough.</li> <li>Bearish signals are obviously dominant (3 bearish vs 0 bullish).</li></ul>

Key Factors

GE HealthCare achieved 115 FDA artificial intelligence authorizations in 2025 and showcased over 40 technology innovations at the RSNA conference.

Recent Updates

GEHC News